Hanlin Zeng

State Key Laboratory Of Drug Research
Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Spliceosomal mutation drives melanoma tumorigenesis via lineage-specific RAS activation.

Spliceosomal mutation drives melanoma tumorigenesis via lineage-specific RAS activation.

Journal: Science advances
Published: May 01, 2026

Tissue-specific inflammation induces cell state plasticity with oncogenic addiction in mucosal melanoma.

Tissue-specific inflammation induces cell state plasticity with oncogenic addiction in mucosal melanoma.

Journal: Science advances
Published: April 01, 2026

FADD Functions as an Oncogene in Chr11q13.3-Amplified Head and Neck Squamous Cell Carcinoma.

FADD Functions as an Oncogene in Chr11q13.3-Amplified Head and Neck Squamous Cell Carcinoma.

Journal: Cancer research
Published: July 23, 2024

Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment.

Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment.

Journal: Journal of experimental & clinical cancer research : CR
Published: July 16, 2024

Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment.

Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment.

Journal: bioRxiv : the preprint server for biology
Published: July 01, 2024

FADD amplification is associated with CD8+ T-cell exclusion and malignant progression in HNSCC.

FADD amplification is associated with CD8+ T-cell exclusion and malignant progression in HNSCC.

Journal: Oral diseases
Published: January 10, 2024

Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer.

Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer.

Journal: Acta pharmaceutica Sinica. B
Published: December 21, 2022

Clinical management of a rare melanoma case arising from congenital melanocytic nevus.

Clinical management of a rare melanoma case arising from congenital melanocytic nevus.

Journal: Genes & diseases
Published: November 10, 2022

The single-cell landscape reveals unique tumor subsets and microenvironments associated with poor clinical outcomes in primary testicular diffuse large B-cell lymphoma.

The single-cell landscape reveals unique tumor subsets and microenvironments associated with poor clinical outcomes in primary testicular diffuse large B-cell lymphoma.

Journal: Genes & diseases
Published: October 09, 2022

Clinical utilization of olaparib, a PARP inhibitor, in BRCA1-mutant metastatic acral melanoma.

Clinical utilization of olaparib, a PARP inhibitor, in BRCA1-mutant metastatic acral melanoma.

Journal: Genes & diseases
Published: July 26, 2022

Mucosal Melanoma: Pathological Evolution, Pathway Dependency and Targeted Therapy.

Mucosal Melanoma: Pathological Evolution, Pathway Dependency and Targeted Therapy.

Journal: Frontiers in oncology
Published: April 29, 2021

Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer.

Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer.

Journal: Cancer cell
Published: January 26, 2016
Showing 1-12 of 14

Last Updated: 09/26/2026